Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study

AIM: The wearable cardioverter‐defibrillator (WCD) is used for temporary protection from sudden cardiac death (SCD) in patients with newly diagnosed heart failure with reduced ejection fraction before considering an implantable cardioverter‐defibrillator (ICD). However, the prognostic significance o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller‐Leisse, Johanna, Brunn, Johanna, Zormpas, Christos, Hohmann, Stephan, Hillmann, Henrike Aenne Katrin, Eiringhaus, Jörg, Bauersachs, Johann, Veltmann, Christian, Duncker, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712878/
https://www.ncbi.nlm.nih.gov/pubmed/34480414
http://dx.doi.org/10.1002/ehf2.13586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712878/
https://www.ncbi.nlm.nih.gov/pubmed/34480414
http://dx.doi.org/10.1002/ehf2.13586

Ejemplares similares